Patents by Inventor Susanne Peters, nee Piwek

Susanne Peters, nee Piwek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6127426
    Abstract: Therapeutic compositions comprising 1,8-dihyroxy-9(10H) anthracenones substituted at position 10 thereof with phenylalkylidene or arylacyl blacking moieties, said compounds having substantial therapeutic activity and minimal inflammatory effect.
    Type: Grant
    Filed: November 19, 1998
    Date of Patent: October 3, 2000
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Klaus Muller, Wolfgang Wiegrebe, Dieter Gurster, Susanne Peters, nee Piwek
  • Patent number: 5844004
    Abstract: Therapeutic compositions comprising 1,8-dihyroxy-9(10H) anthracenones substituted at position 10 thereof with phenylalkylidene or arylacyl blocking moieties, said compounds having substantial therapeutic activity and minimal inflammatory effect.
    Type: Grant
    Filed: March 27, 1997
    Date of Patent: December 1, 1998
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Klaus Muller, Wolfgang Wiegrebe, Dieter Gurster, Susanne Peters, nee Piwek
  • Patent number: 5661187
    Abstract: Therapeutic compositions comprising 1,8-dihyroxy-9(10H) anthracenones substituted at position 10 thereof with phenylalkylidene or arylacyl blocking moieties, said compounds having substantial therapeutic activity and minimal inflammatory effect.
    Type: Grant
    Filed: March 7, 1995
    Date of Patent: August 26, 1997
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Klaus Muller, Wolfgang Wiegrebe, Dieter Gurster, Susanne Peters, nee Piwek
  • Patent number: 5426197
    Abstract: Therapeutic compositions comprising 1,8-dihyroxy-9(10H) anthracenones substituted at position 10 thereof with phenylalkylidene or arylacyl blocking moieties, said compounds having substantial therapeutic activity and minimal inflammatory effect.
    Type: Grant
    Filed: July 19, 1993
    Date of Patent: June 20, 1995
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Klaus Muller, Wolfgang Wiegrebe, Dieter Gurster, Susanne Peters, nee Piwek